Serum Institute seeks DCGI nod for Covid vaccine Covovax

New Delhi, Oct 29: The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufacture COVID-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said.

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News